4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000016
President and CEO sold 2,000 shares at an average $12.72 ($25,435)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2022-08-29 | Sale | −1,109 | $12.56 | $13,931 | 207,601 | D |
| Doshi Dipal President and CEO | 2022-08-29 | Sale | −505 | $13.51 | $6,822 | 207,096 | D |
| Doshi Dipal President and CEO | 2022-08-29 | Sale | −25 | $14.00 | $350 | 207,071 | D |
| Doshi Dipal President and CEO | 2022-08-30 | Sale | −190 | $12.00 | $2,280 | 206,881 | D |
| Doshi Dipal President and CEO | 2022-08-31 | Sale | −171 | $12.00 | $2,052 | 206,710 | D |
| Open-market sales · 2,000 sh · avg $12.72 · $25,435 | |||||||
Loading xslF345X03/wf-form4_166197928416013.xml…